If you owned Johnson & Johnson (NYSE:JNJ) stock at the beginning of 2013, you're sitting atop gains of more than 20% right now.
Keep Reading →
June 28 - News
This article will present the next company that I see poised to split its shares two for one.
Keep Reading →
June 28 - News
When it comes to early-morning market predictions, U.S. investors often turn to overseas markets as a guide for how U.S. stocks will fare.
Keep Reading →
June 28 - News
It is expected that the death rate from diabetes will top 50% in the next ten years, which will make it a leading cause of death worldwide.
Keep Reading →
June 28 - News
Pfizer Inc. (NYSE:PFE) stock is off to a fine start in 2013.
Keep Reading →
June 28 - News
Bonds are not the only viable option for income investors. Today’s low interest rates being paid on government bonds makes dividend-paying stocks a more savvy choice.
Keep Reading →
June 28 - News
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can't catch a break.
Keep Reading →
June 28 - News
Famed investor Warren Buffett once called the high cost of health care a "tapeworm eating at our economic body." While he might be disgusted by the costs, it hasn't stopped ...
Keep Reading →
June 27 - Hedge Fund Analysis
The Dow Jones Industrial Average (INDEXDJX:.DJI) is down 155 points, or 1.05%, as of 1:15 p.m. EDT as the sell-off in the U.S.
Keep Reading →
June 27 - News
Blue-chip stocks are surging this afternoon following a number of better-than-expected economic reports related to jobs, income, spending, inflation, and home sales.
Keep Reading →
June 27 - News
Exchange-traded funds and socially responsible investing (SRI) have each grown in popularity over the past two decades or so; ETFs for their convenience and SRI to achieve great...
Keep Reading →
June 27 - News
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Keep Reading →
June 27 - News
After the failure of its pipeline products for Alzheimer’s and rheumatoid arthritis, the drug giant Eli Lilly & Co. (NYSE:LLY) finally has some good news to report.
Keep Reading →
June 27 - News
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
Keep Reading →
June 27 - News
From highly-innovative companies like Apple to cyclical companies like U.S.
Keep Reading →
June 27 - News
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Keep Reading →
June 27 - News
Investing in biotech companies can be risky; developing new drugs is a long, expensive, and uncertain process, and there is always considerable regulatory risk in the industry...
Keep Reading →
June 26 - News
Stocks that stand the test of time are often ones that have a diversified product portfolio of world class brands.
Keep Reading →
June 26 - News
I am always excited when a company plans to return more cash to its shareholders in both dividends and share buybacks.
Keep Reading →
June 26 - News
A director at Deloitte Services LP and co-author of The Three Rules: How Exceptional Companies Think, Michael Raynor joins The Fool to share his findings about what makes a company...
Keep Reading →
June 25 - News
Medical firm Johnson & Johnson (NYSE:JNJ) recently announced a private-company acquisition that could have major implications for one of the markets in which it operates.
Keep Reading →
June 25 - News
Editor's Note: Related tickers: Yahoo! Inc. (NASDAQ:YHOO), Bank of America Corp (NYSE:BAC), Goldman Sachs Group, Inc.
Keep Reading →
June 25 - Hedge Funds
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Keep Reading →
June 24 - News
I was just a kid in 1982 when Johnson & Johnson (NYSE:JNJ) was forced to recall its Tylenol capsules, but I remember it like it was yesterday.
Keep Reading →
June 24 - News
There's no question that Abbott Laboratories (NYSE:ABT) started 2013 with a bang. The year began with the spinoff of AbbVie Inc (NYSE:ABBV).
Keep Reading →
June 24 - News
Are investors hitting the brakes on biotech? The biotech sector's one of the most boom-or-bust areas for investors, where fortunes can be won or lost.
Keep Reading →
June 24 - News
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Keep Reading →
June 21 - News
It’s a scary investing world out there.
Keep Reading →
June 20 - News
In May, billionaire Stanley Druckenmiller- the former manager of Duquesne Capital, though he may be better known as one of George Soros’s portfolio managers- filed his 13F for...
Keep Reading →
June 20 - Hedge Funds
Given the recent boost in bond yields, let's compare dividend yields to bond yields for the 30 companies in the Dow Jones Industrial Average .
Keep Reading →
June 19 - News
B&G Foods, Inc. (NYSE:BGS) just announced plans to buy Robert's American Gourmet Food, best known for its Pirates Booty brand.
Keep Reading →
June 19 - News
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
Keep Reading →
June 19 - News
You may know the phrase "..... our favorite holding period is forever," part of a famous line uttered by mega-billionaire investor and philanthropist Warren Buffett.
Keep Reading →
June 18 - News
There have been numerous successful turnarounds for companies after their old CEO’s have been hired back.
Keep Reading →
June 18 - News
In the "Global Burden of Disease" report from the World Health Organization, which was compiled over a 20-year period from 1990 through 2010 using data from 500 researchers from...
Keep Reading →
June 17 - News
When we go to the hospital, the last thing on our mind is that something could go wrong or that we could actually become sicker than when we first went in.
Keep Reading →
June 17 - News
The latest drug to bite the dust is LY2886721, a beta secretase, or BACE, inhibitor.
Keep Reading →
June 17 - News
The slowdown in stock market has also adversely affected leading healthcare companies’ stocks.
Keep Reading →
June 13 - News
Generic producers are often regarded as the safer players within BioPharma.
Keep Reading →
June 13 - News
Celgene Corporation (NASDAQ:CELG) shares have soared more than 46% so far in 2013.
Keep Reading →
June 12 - News
Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE:COO).
Keep Reading →
June 12 - News
Our job here is to examine companies through an investing perspective.
Keep Reading →
June 12 - News
Wall Street fell recently as high-yielding dividend stocks lost their traction.
Keep Reading →
June 11 - News
The tech sector is its own animal. And to remain relevant, companies like Facebook Inc (NASDAQ:FB) spend billions of dollars buying start-ups.
Keep Reading →
June 11 - News
When you stack up Amgen, Inc.
Keep Reading →
June 10 - News
Often referred to as "the silent killer," stroke is the fourth-leading cause of the death in the U.S., behind only heart disease, cancer, and chronic lower respiratory diseases...
Keep Reading →
June 10 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Keep Reading →
June 10 - News
Investors are always looking for new strategies to beat the market over time and build wealth to ensure their financial futures.
Keep Reading →
June 7 - News
You can practice the same rule (although that is no guarantee that you will achieve the success of Buffett), and a good place to start is investing in the companies that make ...
Keep Reading →
June 6 - News